ReviewFrontiers in immunology2022

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.

Maxime Teisseyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.